Global Normal Balloon Catheter Market Size, Demand, Trend Analysis And Forecast With Top Players Analysis: Reviewed Till 2022

To understand the Normal balloon catheter Industry Status worldwide, Fact.MR has included the latest Forecast report titled “Normal Balloon Catheter Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022”, to its vast database. This study offers data about the prime regions operating in the Normal balloon catheter manufacturing sector, along with their production, consumption, revenue and market share details. Further, the intelligent report also anticipates that the market would grow at a constructive CAGR until 2022.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=147

Normal balloon catheter, an innovative medical device, comprises a catheter and a guidewire that is inserted into femoral artery in the legs, or, sometimes into radial artery in arms for treating constricted blood vessels. Generally normal balloon catheter is utilized for preventing blood vessel constriction, which is caused by atherosclerosis, i.e. deposition of the lipid substances in blood vessels.

The number of cardiovascular diseases has been witnessing a rise, along with growing cases of cardiology intervention procedures worldwide. Several governments are providing reimbursement support for people suffering from vascular diseases. There has also been a hike in healthcare expenditure. These factors might favor demand for normal balloon catheters. In addition, various other factors such as growing geriatric population, rising investments in research & development activities concerning normal balloon catheters are expected to pave potential growth opportunities for manufacturers of normal balloon catheters. The global market for balloon catheter is likely to exhibit a moderate growth during 2017 to 2022. Revenues from the global market for normal balloon catheter will reach nearly US$ 2,000 Mn by 2022-end.

Trends Being Observed in the Global Normal Balloon Catheter Market:

1- Rise in interventional cardiology is facilitating use of the normal balloon catheters.

2- Surging prevalence of patients with end stage renal disease have been fueling demand for normal balloon catheters.

3- The number of people undergoing renal replacement therapy is increasing, thereby fueling growth of the normal balloon catheter market

Browse Full Report with TOC- https://www.factmr.com/report/147/normal-balloon-catheter-market

Europe to Account for the Largest Revenue Share of the Market during 2017 to 2022

In terms of revenues, Europe will account for the largest share of the market during the forecast period. Europe will continue to be the most lucrative market for normal balloon catheter. Sales of normal balloon catheter in Asia-Pacific excluding Japan (APEJ) will register the highest CAGR through 2022. In contrast, sales of normal balloon catheter in North America will exhibit the lowest CAGR in the market through 2022.

By indication, coronary artery disease will remain dominant in the global market, with sales poised to surpass US$ 1,000 Mn in revenues by 2022-end. Approximately three-fourth revenue share of the market will be accounted by sales of normal balloon catheter for coronary artery disease during 2017 to 2022.

Hospitals to Remain the Largest End-Users of Normal Balloon Catheter

Sales of normal balloon catheter in cardiac catheterization laboratories are expected to exhibit the fastest expansion through 2022, based on end-users. Hospitals will remain the largest end-users of normal balloon catheter throughout the forecast period.

Nylon will continue to be the preferred raw material for manufacturing normal balloon catheter. Nearly half revenue share of the market will be accounted by nylon, based on raw material. However, sales of polyurethane for production of normal balloon catheter will register a comparatively higher CAGR than sales of nylon through 2022.

Competition Tracking

Key players profiled in Fact.MR’s report include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, MicroPort Scientific Corporation, B. Braun Melsungen AG, Meril Life Sciences Pvt. Ltd., Hexacath, Tokai Medical Products Inc., Cook Medical INC, Cordis Corporation, and BIOTRONIK SE & Co. KG.

Check Discount On This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=147

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.